Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
44 /100
MEDIUM RISK
Score updated Oct 13, 2026

CRDF — Cardiff Oncology, Inc. Dilution Risk Tracker

Track CRDF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CRDF — Get alerts when the score changes →

As of October 13, 2026, Cardiff Oncology, Inc. (CRDF) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Cardiff Oncology, Inc. has a market capitalization of $80.91M, 77.80M shares outstanding, 116 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 24%
🔄 Reverse Split model est. 40%
• 50-day avg $1.69 approaching $1 threshold
• 10 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track CRDF — Get forecast alerts →

Market Data

Market Cap$80.91M
Shares Outstanding77.80M
Float66.71M
Cash$34.52M
Debt$646.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore44/100DilutionWatch score record
Shares Outstanding77.80MVerified float table or market cache
Public Float66.71MVerified float table or market cache
Market Cap$80.91MMarket data cache
Cash Runway10.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 3.6% shares (2026Q1 vs prior)
116 institutional holders · 29.67M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 5.71M shares
#2 BlackRock, Inc. 3.98M shares
#3 Laurion Capital Management LP 2.65M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.07M
Days to Cover17.2
% of Float18.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-11
xbrl XBRL CONVERTIBLE 2024-02-29
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CRDF Dilution Snapshot

Cardiff Oncology, Inc. (CRDF) has a DilutionScore of 44/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CRDF's DilutionScore is currently 44/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 40/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202644/100MEDIUM13 days
Aug 14 – Sep 30, 202640/100MEDIUM47 days
Jul 16 – Aug 13, 202633/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track CRDF Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CRDF files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CRDF — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CRDF
CRDF FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.